Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Northerencentson Apr 06, 2021 7:23pm
146 Views
Post# 32946524

RE:A short math lesson...

RE:A short math lesson...I'm 100% with you there, there is absolutely no bad news here, financials are great! Acquistion is great we get revenue and get Aristotle in the market( keep in mind we aren't buying these guys unless we hit milestones the company has set that means test and money!), we will see all sorts of pieces before the AGM I'm almost sure of it

This blood bath is a big fk you to James in my opinion for displaying arrogance and lack of respect to investors....no clarity missing deadlines no updates hush hush etc. However I think he's hearing it loud and clear and if he doesn't there is a good chance he gets the boot..personally I hope not he's the man for the job as ceo if he can clean up his act 

other then that there is not one good reason for this to not have doubled or even triple in market cap let alone decrease fundamentaly speaking ....prove me wrong 
<< Previous
Bullboard Posts
Next >>